Cyclophosphamide plus dexamethasone is an efficient initial treatment before high-dose melphalan and autologous stem cell transplantation in patients with newly diagnosed multiple myeloma: results of a randomized comparison with vincristine, doxorub (Q81527959)
Jump to navigation
Jump to search
scientific article published on 01 January 2008
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Cyclophosphamide plus dexamethasone is an efficient initial treatment before high-dose melphalan and autologous stem cell transplantation in patients with newly diagnosed multiple myeloma: results of a randomized comparison with vincristine, doxorub |
scientific article published on 01 January 2008 |
Statements
Cyclophosphamide plus dexamethasone is an efficient initial treatment before high-dose melphalan and autologous stem cell transplantation in patients with newly diagnosed multiple myeloma: results of a randomized comparison with vincristine, doxorubicin, and dexamethasone (English)
Ulf-Henrik Mellqvist
Stig Lenhoff
Martin Hjorth
Gunnar Juliusson
Jon Magnus Tangen
Jan Westin
Nordic Myeloma Study Group